Lipid Accumulation Product strongest Predictor of Diabetes Among Visceral Obesity Indices: Study
China: A new prospective cohort study from China has provided fresh insights into the link between visceral obesity and the future risk of developing diabetes mellitus (DM). Conducted by Dr. Yue Zhang and colleagues from the People's Liberation Army Medical School in Beijing, the research highlights the clinical significance of various visceral fat markers and positions the Lipid Accumulation Product (LAP) as the most powerful predictor of diabetes onset.
Published in Diabetes, Obesity and Metabolism, the study involved 6,575 participants aged 40 years and older who were free from diabetes at the beginning of the study. These individuals were followed over an average period of 3.19 years, during which their metabolic health was monitored. For the follow-up, 752 participants (11.4%) developed diabetes.
To assess the relationship between visceral fat and diabetes risk, the researchers examined five specific visceral obesity indices: waist-to-height ratio (WHtR), body roundness index (BRI), visceral adiposity index (VAI), abdominal body shape index (ABSI), and LAP. These indices were analyzed using multivariable-adjusted Cox proportional hazards models. Additionally, restricted cubic spline (RCS) models were used to evaluate dose-response relationships, and ROC curve analysis was conducted to assess the predictive accuracy of each index.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.